Fuji Pharma Co Ltd banner

Fuji Pharma Co Ltd
F:FUP

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
F:FUP
Watchlist
Price: 9.5 EUR
Market Cap: €231m

Wall St Price Targets

FUP Price Targets Summary
Fuji Pharma Co Ltd

Wall Street analysts forecast FUP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FUP is 14.36 EUR with a low forecast of 11.09 EUR and a high forecast of 18.04 EUR.

Lowest Forecast
Price Target
11.09 EUR
17% Upside
Average Forecast
Price Target
14.36 EUR
51% Upside
Highest Forecast
Price Target
18.04 EUR
90% Upside
Fuji Pharma Co Ltd Competitors:
Price Targets

Revenue
Forecast

7% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 12%.

Gross Profit
Forecast

6% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 16%.

Operating Income
Forecast

5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Fuji Pharma Co Ltd

Pre-Tax Income
Forecast

4% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
4% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 29%.

Net Income
Forecast

6% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 26%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FUP's stock price target?
Price Target
14.36 EUR

According to Wall Street analysts, the average 1-year price target for FUP is 14.36 EUR with a low forecast of 11.09 EUR and a high forecast of 18.04 EUR.

What is the Revenue forecast for Fuji Pharma Co Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 12%.

What is the Gross Profit forecast for Fuji Pharma Co Ltd?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 16%.

What is the Pre-Tax Income forecast for Fuji Pharma Co Ltd?
Projected CAGR
29%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 29%.

What is the Net Income forecast for Fuji Pharma Co Ltd?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett